195 related articles for article (PubMed ID: 18245471)
21. Nuclear addressing provides a clue for the transforming activity of amino-truncated CCN3 proteins.
Planque N; Long Li C; Saule S; Bleau AM; Perbal B
J Cell Biochem; 2006 Sep; 99(1):105-16. PubMed ID: 16598765
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of CCN3 in osteosarcoma.
Perbal B; Zuntini M; Zambelli D; Serra M; Sciandra M; Cantiani L; Lucarelli E; Picci P; Scotlandi K
Clin Cancer Res; 2008 Feb; 14(3):701-9. PubMed ID: 18245529
[TBL] [Abstract][Full Text] [Related]
23. CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1.
Fukunaga-Kalabis M; Martinez G; Liu ZJ; Kalabis J; Mrass P; Weninger W; Firth SM; Planque N; Perbal B; Herlyn M
J Cell Biol; 2006 Nov; 175(4):563-9. PubMed ID: 17101694
[TBL] [Abstract][Full Text] [Related]
24. A role for CCN3 (NOV) in calcium signalling.
Li CL; Martinez V; He B; Lombet A; Perbal B
Mol Pathol; 2002 Aug; 55(4):250-61. PubMed ID: 12147716
[TBL] [Abstract][Full Text] [Related]
25. Dose-dependent differential upregulation of CCN1/Cyr61 and CCN3/NOV by the gap junction protein Connexin43 in glioma cells.
Sin WC; Bechberger JF; Rushlow WJ; Naus CC
J Cell Biochem; 2008 Apr; 103(6):1772-82. PubMed ID: 18004727
[TBL] [Abstract][Full Text] [Related]
26. Proposal for a unified CCN nomenclature.
Brigstock DR; Goldschmeding R; Katsube KI; Lam SC; Lau LF; Lyons K; Naus C; Perbal B; Riser B; Takigawa M; Yeger H
Mol Pathol; 2003 Apr; 56(2):127-8. PubMed ID: 12665631
[TBL] [Abstract][Full Text] [Related]
27. Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.
Nip J; Rabbani SA; Shibata HR; Brodt P
J Clin Invest; 1995 May; 95(5):2096-103. PubMed ID: 7537755
[TBL] [Abstract][Full Text] [Related]
28. NOV/CCN3 induces adhesion of muscle skeletal cells and cooperates with FGF2 and IGF-1 to promote proliferation and survival.
Lafont J; Thibout H; Dubois C; Laurent M; Martinerie C
Cell Commun Adhes; 2005; 12(1-2):41-57. PubMed ID: 16371345
[TBL] [Abstract][Full Text] [Related]
29. CCN3 increases cell motility and ICAM-1 expression in prostate cancer cells.
Chen PC; Lin TH; Cheng HC; Tang CH
Carcinogenesis; 2012 Apr; 33(4):937-45. PubMed ID: 22345292
[TBL] [Abstract][Full Text] [Related]
30. Matricellular protein CCN3 (NOV) regulates actin cytoskeleton reorganization.
Sin WC; Tse M; Planque N; Perbal B; Lampe PD; Naus CC
J Biol Chem; 2009 Oct; 284(43):29935-44. PubMed ID: 19706598
[TBL] [Abstract][Full Text] [Related]
31. Elevated expression of Cyr61 enhances peritoneal dissemination of gastric cancer cells through integrin alpha2beta1.
Lin MT; Chang CC; Lin BR; Yang HY; Chu CY; Wu MH; Kuo ML
J Biol Chem; 2007 Nov; 282(47):34594-604. PubMed ID: 17905740
[TBL] [Abstract][Full Text] [Related]
32. CCN3 increases cell motility and MMP-13 expression in human chondrosarcoma through integrin-dependent pathway.
Tzeng HE; Chen JC; Tsai CH; Kuo CC; Hsu HC; Hwang WL; Fong YC; Tang CH
J Cell Physiol; 2011 Dec; 226(12):3181-9. PubMed ID: 21344378
[TBL] [Abstract][Full Text] [Related]
33. The CCN3 (NOV) cell growth regulator: a new tool for molecular medicine.
Perbal B
Expert Rev Mol Diagn; 2003 Sep; 3(5):597-604. PubMed ID: 14510180
[TBL] [Abstract][Full Text] [Related]
34. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells.
Luo X; Ding L; Chegini N
Mol Hum Reprod; 2006 Apr; 12(4):245-56. PubMed ID: 16571622
[TBL] [Abstract][Full Text] [Related]
35. Abnormal skeletal and cardiac development, cardiomyopathy, muscle atrophy and cataracts in mice with a targeted disruption of the Nov (Ccn3) gene.
Heath E; Tahri D; Andermarcher E; Schofield P; Fleming S; Boulter CA
BMC Dev Biol; 2008 Feb; 8():18. PubMed ID: 18289368
[TBL] [Abstract][Full Text] [Related]
36. Expression of CCN3 protein in human Wilms' tumors: immunohistochemical detection of CCN3 variants using domain-specific antibodies.
Subramaniam MM; Lazar N; Navarro S; Perbal B; Llombart-Bosch A
Virchows Arch; 2008 Jan; 452(1):33-9. PubMed ID: 18066593
[TBL] [Abstract][Full Text] [Related]
37. Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells.
Gery S; Xie D; Yin D; Gabra H; Miller C; Wang H; Scott D; Yi WS; Popoviciu ML; Said JW; Koeffler HP
Clin Cancer Res; 2005 Oct; 11(20):7243-54. PubMed ID: 16243794
[TBL] [Abstract][Full Text] [Related]
38. Adenoviral CCN3/NOV gene transfer fails to mitigate liver fibrosis in an experimental bile duct ligation model because of hepatocyte apoptosis.
Borkham-Kamphorst E; Huss S; Van de Leur E; Haas U; Weiskirchen R
Liver Int; 2012 Oct; 32(9):1342-53. PubMed ID: 22698069
[TBL] [Abstract][Full Text] [Related]
39. CCN3 (NOV) regulates proliferation, adhesion, migration and invasion in clear cell renal cell carcinoma.
Liu S; Liu Z; Bi D; Yuan X; Liu X; Ding S; Lu J; Niu Z
Oncol Lett; 2012 May; 3(5):1099-1104. PubMed ID: 22783399
[TBL] [Abstract][Full Text] [Related]
40. NOV (CCN3) regulation in the growth plate and CCN family member expression in cartilage neoplasia.
Yu C; Le AT; Yeger H; Perbal B; Alman BA
J Pathol; 2003 Dec; 201(4):609-15. PubMed ID: 14648665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
